- 數(shù)據(jù)庫(kù)收錄SCIE
- 年發(fā)文量21
Hepatic Medicine-evidence And Research
期刊中文名：肝病醫(yī)學(xué)證據(jù)與研究ISSN：1179-1535
該雜志國(guó)際簡(jiǎn)稱(chēng)：HEPATIC MED-EVID RES，是由出版商Dove Medical Press出版的一本致力于發(fā)布--研究新成果的的專(zhuān)業(yè)學(xué)術(shù)期刊。主要發(fā)表刊登有創(chuàng)見(jiàn)的學(xué)術(shù)論文文章、行業(yè)最新科研成果，扼要報(bào)道階段性研究成果和重要研究工作的最新進(jìn)展，選載對(duì)學(xué)科發(fā)展起指導(dǎo)作用的綜述與專(zhuān)論，促進(jìn)學(xué)術(shù)發(fā)展，為廣大讀者服務(wù)。該刊是一本國(guó)際優(yōu)秀雜志，在國(guó)際上有很高的學(xué)術(shù)影響力。
雜志介紹
Hepatic Medicine-evidence And Research雜志介紹
《Hepatic Medicine-evidence And Research》是一本以English為主的開(kāi)放獲取國(guó)際優(yōu)秀期刊，中文名稱(chēng)肝病醫(yī)學(xué)證據(jù)與研究，本刊主要出版、報(bào)道領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專(zhuān)業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專(zhuān)業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為2.6，
英文介紹
Hepatic Medicine-evidence And Research雜志英文介紹
Hepatic Medicine Evidence and Research is an international peer-reviewed medical journal dedicated to liver disease, dedicated to publishing clinical studies, case reports, reviews, and expert opinions on liver disease. This journal emphasizes evidence-based medical practice, aiming to provide scientific basis for the prevention, diagnosis, and treatment of liver diseases. It covers research on various liver diseases, from viral hepatitis to fatty liver, cirrhosis, and liver cancer, and is an important source of information for liver specialists and researchers.
The characteristic of the magazine lies in its emphasis on high-quality clinical research, which can directly affect clinical decision-making and patient care. The editorial committee of the journal is composed of internationally renowned liver disease experts, ensuring the scientific and practical nature of the published articles. In addition, the journal is indexed in multiple databases, including PubMed Central, which increases its visibility and influence in the international medical community. It is one of the authoritative journals in the field of liver disease and a valuable resource for medical professionals who wish to access the latest clinical research and treatment progress. By reading this journal, professionals can maintain an understanding of the latest research in the field of liver disease treatment and apply this knowledge to their daily clinical practice.
JCR分區(qū)（2023-2024年最新版）
Hepatic Medicine-evidence And Research雜志 JCR分區(qū)信息
| 按JIF指標(biāo)學(xué)科分區(qū) |
學(xué)科：GASTROENTEROLOGY & HEPATOLOGY
收錄子集：ESCI
分區(qū)：Q2
排名：67 / 143
百分位：
53.5% |
| 按JCI指標(biāo)學(xué)科分區(qū) |
學(xué)科：GASTROENTEROLOGY & HEPATOLOGY
收錄子集：ESCI
分區(qū)：Q3
排名：96 / 143
百分位：
33.22% |
JCR分區(qū)：JCR分區(qū)來(lái)自科睿唯安公司,JCR是一個(gè)獨(dú)特的多學(xué)科期刊評(píng)價(jià)工具，為唯一提供基于引文數(shù)據(jù)的統(tǒng)計(jì)信息的期刊評(píng)價(jià)資源。每年發(fā)布的JCR分區(qū)，設(shè)置了254個(gè)具體學(xué)科。JCR分區(qū)根據(jù)每個(gè)學(xué)科分類(lèi)按照期刊當(dāng)年的影響因子高低將期刊平均分為4個(gè)區(qū)，分別為Q1、Q2、Q3和Q4，各占25%。JCR分區(qū)中期刊的數(shù)量是均勻分為四個(gè)部分的。
CiteScore 評(píng)價(jià)數(shù)據(jù)（2024年最新版）
Hepatic Medicine-evidence And Research雜志CiteScore 評(píng)價(jià)數(shù)據(jù)
歷年影響因子和期刊自引率
投稿經(jīng)驗(yàn)
Hepatic Medicine-evidence And Research雜志投稿經(jīng)驗(yàn)
該雜志是一本國(guó)際優(yōu)秀雜志，在國(guó)際上有較高的學(xué)術(shù)影響力，行業(yè)關(guān)注度很高，已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，該雜志在綜合專(zhuān)業(yè)領(lǐng)域?qū)I(yè)度認(rèn)可很高，對(duì)稿件內(nèi)容的創(chuàng)新性和學(xué)術(shù)性要求很高，作為一本國(guó)際優(yōu)秀雜志，一般投稿過(guò)審時(shí)間都較長(zhǎng)，投稿過(guò)審時(shí)間平均 16 Weeks ，如果想投稿該刊要做好時(shí)間安排。版面費(fèi)不祥。該雜志近兩年未被列入預(yù)警名單，建議您投稿。如您想了解更多投稿政策及投稿方案，請(qǐng)咨詢(xún)客服。
免責(zé)聲明
若用戶(hù)需要出版服務(wù)，請(qǐng)聯(lián)系出版商。